UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

The future of ATTR management

Source
King’s College London

The future of ATTR management

Amyloid cardiomyopathy, particularly transthyretin (ATTR) amyloidosis, has undergone a profound therapeutic transformation over the past decade. Initial strategies focused on reducing the production of misfolded transthyretin through gene silencers and stabilisers, effectively slowing disease progression and improving outcomes. However, these approaches do not address the substantial burden of pre-existing amyloid deposits within the myocardium, which continue to drive cardiac dysfunction, particularly in advanced disease.